Investors might want to bet on Open Lending (LPRO), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one ...
Solventum (SOLV) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...
Introduction The aetiology of eating disorders (EDs) is complex, involving an interplay of genetic and environmental factors. Children at familial high risk (FHR) for EDs demonstrate increased risk of ...
Q3 2025 Earnings Call November 11, 2025 3:00 AM ESTCompany ParticipantsStephan Gramkow - Head of Investor RelationsAndreas ...
Health Catalyst, Inc. ( HCAT) Q3 2025 Earnings Call November 10, 2025 5:00 PM EST Welcome to the Health Catalyst Third Quarter 2025 Earnings Conference Call. [Operator Instructions] I would now like ...
INOVIO , a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced ...